Global HMO Infant Formula Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 HMO Infant Formula Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global HMO Infant Formula Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 2'-Fucosyllactose (2'-FL)
  • 1.2.3 3-Fucosyllactose (3-FL)
  • 1.2.4 Lactose-N-neotetraose (LNnT)
  • 1.2.5 3'-Sialyllactose (3'-SL)
  • 1.2.6 6'-Sialyllactose (6'-SL)
• 1.3 Market by Application
  • 1.3.1 Global HMO Infant Formula Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Online Channel
  • 1.3.3 Specialty Store
  • 1.3.4 Supermarket
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global HMO Infant Formula Sales Estimates and Forecasts 2018-2029
• 2.2 Global HMO Infant Formula Revenue by Region
  • 2.2.1 Global HMO Infant Formula Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global HMO Infant Formula Revenue by Region (2018-2023)
  • 2.2.3 Global HMO Infant Formula Revenue by Region (2024-2029)
  • 2.2.4 Global HMO Infant Formula Revenue Market Share by Region (2018-2029)
• 2.3 Global HMO Infant Formula Sales Estimates and Forecasts 2018-2029
• 2.4 Global HMO Infant Formula Sales by Region
  • 2.4.1 Global HMO Infant Formula Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global HMO Infant Formula Sales by Region (2018-2023)
  • 2.4.3 Global HMO Infant Formula Sales by Region (2024-2029)
  • 2.4.4 Global HMO Infant Formula Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global HMO Infant Formula Sales by Manufacturers
  • 3.1.1 Global HMO Infant Formula Sales by Manufacturers (2018-2023)
  • 3.1.2 Global HMO Infant Formula Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of HMO Infant Formula in 2022
• 3.2 Global HMO Infant Formula Revenue by Manufacturers
  • 3.2.1 Global HMO Infant Formula Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global HMO Infant Formula Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by HMO Infant Formula Revenue in 2022
• 3.3 Global Key Players of HMO Infant Formula, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global HMO Infant Formula Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of HMO Infant Formula, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of HMO Infant Formula, Product Offered and Application
• 3.8 Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global HMO Infant Formula Sales by Type
  • 4.1.1 Global HMO Infant Formula Historical Sales by Type (2018-2023)
  • 4.1.2 Global HMO Infant Formula Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global HMO Infant Formula Sales Market Share by Type (2018-2029)
• 4.2 Global HMO Infant Formula Revenue by Type
  • 4.2.1 Global HMO Infant Formula Historical Revenue by Type (2018-2023)
  • 4.2.2 Global HMO Infant Formula Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global HMO Infant Formula Revenue Market Share by Type (2018-2029)
• 4.3 Global HMO Infant Formula Price by Type
  • 4.3.1 Global HMO Infant Formula Price by Type (2018-2023)
  • 4.3.2 Global HMO Infant Formula Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global HMO Infant Formula Sales by Application
  • 5.1.1 Global HMO Infant Formula Historical Sales by Application (2018-2023)
  • 5.1.2 Global HMO Infant Formula Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global HMO Infant Formula Sales Market Share by Application (2018-2029)
• 5.2 Global HMO Infant Formula Revenue by Application
  • 5.2.1 Global HMO Infant Formula Historical Revenue by Application (2018-2023)
  • 5.2.2 Global HMO Infant Formula Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global HMO Infant Formula Revenue Market Share by Application (2018-2029)
• 5.3 Global HMO Infant Formula Price by Application
  • 5.3.1 Global HMO Infant Formula Price by Application (2018-2023)
  • 5.3.2 Global HMO Infant Formula Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada HMO Infant Formula Market Size by Type
  • 6.1.1 US & Canada HMO Infant Formula Sales by Type (2018-2029)
  • 6.1.2 US & Canada HMO Infant Formula Revenue by Type (2018-2029)
• 6.2 US & Canada HMO Infant Formula Market Size by Application
  • 6.2.1 US & Canada HMO Infant Formula Sales by Application (2018-2029)
  • 6.2.2 US & Canada HMO Infant Formula Revenue by Application (2018-2029)
• 6.3 US & Canada HMO Infant Formula Market Size by Country
  • 6.3.1 US & Canada HMO Infant Formula Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada HMO Infant Formula Sales by Country (2018-2029)
  • 6.3.3 US & Canada HMO Infant Formula Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe HMO Infant Formula Market Size by Type
  • 7.1.1 Europe HMO Infant Formula Sales by Type (2018-2029)
  • 7.1.2 Europe HMO Infant Formula Revenue by Type (2018-2029)
• 7.2 Europe HMO Infant Formula Market Size by Application
  • 7.2.1 Europe HMO Infant Formula Sales by Application (2018-2029)
  • 7.2.2 Europe HMO Infant Formula Revenue by Application (2018-2029)
• 7.3 Europe HMO Infant Formula Market Size by Country
  • 7.3.1 Europe HMO Infant Formula Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe HMO Infant Formula Sales by Country (2018-2029)
  • 7.3.3 Europe HMO Infant Formula Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China HMO Infant Formula Market Size
  • 8.1.1 China HMO Infant Formula Sales (2018-2029)
  • 8.1.2 China HMO Infant Formula Revenue (2018-2029)
• 8.2 China HMO Infant Formula Market Size by Application
  • 8.2.1 China HMO Infant Formula Sales by Application (2018-2029)
  • 8.2.2 China HMO Infant Formula Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia HMO Infant Formula Market Size by Type
  • 9.1.1 Asia HMO Infant Formula Sales by Type (2018-2029)
  • 9.1.2 Asia HMO Infant Formula Revenue by Type (2018-2029)
• 9.2 Asia HMO Infant Formula Market Size by Application
  • 9.2.1 Asia HMO Infant Formula Sales by Application (2018-2029)
  • 9.2.2 Asia HMO Infant Formula Revenue by Application (2018-2029)
• 9.3 Asia HMO Infant Formula Sales by Region
  • 9.3.1 Asia HMO Infant Formula Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia HMO Infant Formula Revenue by Region (2018-2029)
  • 9.3.3 Asia HMO Infant Formula Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America HMO Infant Formula Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America HMO Infant Formula Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America HMO Infant Formula Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America HMO Infant Formula Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America HMO Infant Formula Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America HMO Infant Formula Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America HMO Infant Formula Sales by Country
  • 10.3.1 Middle East, Africa and Latin America HMO Infant Formula Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America HMO Infant Formula Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America HMO Infant Formula Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Abbott
  • 11.1.1 Abbott Company Information
  • 11.1.2 Abbott Overview
  • 11.1.3 Abbott HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Abbott HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Abbott Recent Developments
• 11.2 Nestle
  • 11.2.1 Nestle Company Information
  • 11.2.2 Nestle Overview
  • 11.2.3 Nestle HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Nestle HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Nestle Recent Developments
• 11.3 Wyeth Nutrition
  • 11.3.1 Wyeth Nutrition Company Information
  • 11.3.2 Wyeth Nutrition Overview
  • 11.3.3 Wyeth Nutrition HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Wyeth Nutrition HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Wyeth Nutrition Recent Developments
• 11.4 Hoeslandt
  • 11.4.1 Hoeslandt Company Information
  • 11.4.2 Hoeslandt Overview
  • 11.4.3 Hoeslandt HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 Hoeslandt HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Hoeslandt Recent Developments
• 11.5 Friesland Foods
  • 11.5.1 Friesland Foods Company Information
  • 11.5.2 Friesland Foods Overview
  • 11.5.3 Friesland Foods HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Friesland Foods HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Friesland Foods Recent Developments
• 11.6 Hyproca
  • 11.6.1 Hyproca Company Information
  • 11.6.2 Hyproca Overview
  • 11.6.3 Hyproca HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 Hyproca HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Hyproca Recent Developments
• 11.7 Aptamil
  • 11.7.1 Aptamil Company Information
  • 11.7.2 Aptamil Overview
  • 11.7.3 Aptamil HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Aptamil HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Aptamil Recent Developments
• 11.8 Biostime
  • 11.8.1 Biostime Company Information
  • 11.8.2 Biostime Overview
  • 11.8.3 Biostime HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 Biostime HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Biostime Recent Developments
• 11.9 Mengniu Dairy
  • 11.9.1 Mengniu Dairy Company Information
  • 11.9.2 Mengniu Dairy Overview
  • 11.9.3 Mengniu Dairy HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.9.4 Mengniu Dairy HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Mengniu Dairy Recent Developments
• 11.10 Yili Group
  • 11.10.1 Yili Group Company Information
  • 11.10.2 Yili Group Overview
  • 11.10.3 Yili Group HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.10.4 Yili Group HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Yili Group Recent Developments
• 11.11 Feihe
  • 11.11.1 Feihe Company Information
  • 11.11.2 Feihe Overview
  • 11.11.3 Feihe HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.11.4 Feihe HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Feihe Recent Developments
• 11.12 Junlebao Dairy Group
  • 11.12.1 Junlebao Dairy Group Company Information
  • 11.12.2 Junlebao Dairy Group Overview
  • 11.12.3 Junlebao Dairy Group HMO Infant Formula Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.12.4 Junlebao Dairy Group HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Junlebao Dairy Group Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 HMO Infant Formula Industry Chain Analysis
• 12.2 HMO Infant Formula Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 HMO Infant Formula Production Mode & Process
• 12.4 HMO Infant Formula Sales and Marketing
  • 12.4.1 HMO Infant Formula Sales Channels
  • 12.4.2 HMO Infant Formula Distributors
• 12.5 HMO Infant Formula Customers

13 Market Dynamics

• 13.1 HMO Infant Formula Industry Trends
• 13.2 HMO Infant Formula Market Drivers
• 13.3 HMO Infant Formula Market Challenges
• 13.4 HMO Infant Formula Market Restraints

14 Key Findings in The Global HMO Infant Formula Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global HMO Infant Formula Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of 2'-Fucosyllactose (2'-FL)
• Table 3. Major Manufacturers of 3-Fucosyllactose (3-FL)
• Table 4. Major Manufacturers of Lactose-N-neotetraose (LNnT)
• Table 5. Major Manufacturers of 3'-Sialyllactose (3'-SL)
• Table 6. Major Manufacturers of 6'-Sialyllactose (6'-SL)
• Table 7. Global HMO Infant Formula Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 8. Global HMO Infant Formula Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 9. Global HMO Infant Formula Revenue by Region (2018-2023) & (US$ Million)
• Table 10. Global HMO Infant Formula Revenue by Region (2024-2029) & (US$ Million)
• Table 11. Global HMO Infant Formula Revenue Market Share by Region (2018-2023)
• Table 12. Global HMO Infant Formula Revenue Market Share by Region (2024-2029)
• Table 13. Global HMO Infant Formula Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 14. Global HMO Infant Formula Sales by Region (2018-2023) & (Tons)
• Table 15. Global HMO Infant Formula Sales by Region (2024-2029) & (Tons)
• Table 16. Global HMO Infant Formula Sales Market Share by Region (2018-2023)
• Table 17. Global HMO Infant Formula Sales Market Share by Region (2024-2029)
• Table 18. Global HMO Infant Formula Sales by Manufacturers (2018-2023) & (Tons)
• Table 19. Global HMO Infant Formula Sales Share by Manufacturers (2018-2023)
• Table 20. Global HMO Infant Formula Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 21. Global HMO Infant Formula Revenue Share by Manufacturers (2018-2023)
• Table 22. Global Key Players of HMO Infant Formula, Industry Ranking, 2021 VS 2022 VS 2023
• Table 23. HMO Infant Formula Price by Manufacturers 2018-2023 (US$/Ton)
• Table 24. Global HMO Infant Formula Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 25. Global HMO Infant Formula by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMO Infant Formula as of 2022)
• Table 26. Global Key Manufacturers of HMO Infant Formula, Manufacturing Base Distribution and Headquarters
• Table 27. Global Key Manufacturers of HMO Infant Formula, Product Offered and Application
• Table 28. Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry
• Table 29. Mergers & Acquisitions, Expansion Plans
• Table 30. Global HMO Infant Formula Sales by Type (2018-2023) & (Tons)
• Table 31. Global HMO Infant Formula Sales by Type (2024-2029) & (Tons)
• Table 32. Global HMO Infant Formula Sales Share by Type (2018-2023)
• Table 33. Global HMO Infant Formula Sales Share by Type (2024-2029)
• Table 34. Global HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
• Table 35. Global HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
• Table 36. Global HMO Infant Formula Revenue Share by Type (2018-2023)
• Table 37. Global HMO Infant Formula Revenue Share by Type (2024-2029)
• Table 38. HMO Infant Formula Price by Type (2018-2023) & (US$/Ton)
• Table 39. Global HMO Infant Formula Price Forecast by Type (2024-2029) & (US$/Ton)
• Table 40. Global HMO Infant Formula Sales by Application (2018-2023) & (Tons)
• Table 41. Global HMO Infant Formula Sales by Application (2024-2029) & (Tons)
• Table 42. Global HMO Infant Formula Sales Share by Application (2018-2023)
• Table 43. Global HMO Infant Formula Sales Share by Application (2024-2029)
• Table 44. Global HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
• Table 45. Global HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
• Table 46. Global HMO Infant Formula Revenue Share by Application (2018-2023)
• Table 47. Global HMO Infant Formula Revenue Share by Application (2024-2029)
• Table 48. HMO Infant Formula Price by Application (2018-2023) & (US$/Ton)
• Table 49. Global HMO Infant Formula Price Forecast by Application (2024-2029) & (US$/Ton)
• Table 50. US & Canada HMO Infant Formula Sales by Type (2018-2023) & (Tons)
• Table 51. US & Canada HMO Infant Formula Sales by Type (2024-2029) & (Tons)
• Table 52. US & Canada HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
• Table 53. US & Canada HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
• Table 54. US & Canada HMO Infant Formula Sales by Application (2018-2023) & (Tons)
• Table 55. US & Canada HMO Infant Formula Sales by Application (2024-2029) & (Tons)
• Table 56. US & Canada HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
• Table 57. US & Canada HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
• Table 58. US & Canada HMO Infant Formula Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 59. US & Canada HMO Infant Formula Revenue by Country (2018-2023) & (US$ Million)
• Table 60. US & Canada HMO Infant Formula Revenue by Country (2024-2029) & (US$ Million)
• Table 61. US & Canada HMO Infant Formula Sales by Country (2018-2023) & (Tons)
• Table 62. US & Canada HMO Infant Formula Sales by Country (2024-2029) & (Tons)
• Table 63. Europe HMO Infant Formula Sales by Type (2018-2023) & (Tons)
• Table 64. Europe HMO Infant Formula Sales by Type (2024-2029) & (Tons)
• Table 65. Europe HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
• Table 66. Europe HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
• Table 67. Europe HMO Infant Formula Sales by Application (2018-2023) & (Tons)
• Table 68. Europe HMO Infant Formula Sales by Application (2024-2029) & (Tons)
• Table 69. Europe HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
• Table 70. Europe HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
• Table 71. Europe HMO Infant Formula Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 72. Europe HMO Infant Formula Revenue by Country (2018-2023) & (US$ Million)
• Table 73. Europe HMO Infant Formula Revenue by Country (2024-2029) & (US$ Million)
• Table 74. Europe HMO Infant Formula Sales by Country (2018-2023) & (Tons)
• Table 75. Europe HMO Infant Formula Sales by Country (2024-2029) & (Tons)
• Table 76. China HMO Infant Formula Sales by Type (2018-2023) & (Tons)
• Table 77. China HMO Infant Formula Sales by Type (2024-2029) & (Tons)
• Table 78. China HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
• Table 79. China HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
• Table 80. China HMO Infant Formula Sales by Application (2018-2023) & (Tons)
• Table 81. China HMO Infant Formula Sales by Application (2024-2029) & (Tons)
• Table 82. China HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
• Table 83. China HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
• Table 84. Asia HMO Infant Formula Sales by Type (2018-2023) & (Tons)
• Table 85. Asia HMO Infant Formula Sales by Type (2024-2029) & (Tons)
• Table 86. Asia HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
• Table 87. Asia HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
• Table 88. Asia HMO Infant Formula Sales by Application (2018-2023) & (Tons)
• Table 89. Asia HMO Infant Formula Sales by Application (2024-2029) & (Tons)
• Table 90. Asia HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
• Table 91. Asia HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
• Table 92. Asia HMO Infant Formula Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 93. Asia HMO Infant Formula Revenue by Region (2018-2023) & (US$ Million)
• Table 94. Asia HMO Infant Formula Revenue by Region (2024-2029) & (US$ Million)
• Table 95. Asia HMO Infant Formula Sales by Region (2018-2023) & (Tons)
• Table 96. Asia HMO Infant Formula Sales by Region (2024-2029) & (Tons)
• Table 97. Middle East, Africa and Latin America HMO Infant Formula Sales by Type (2018-2023) & (Tons)
• Table 98. Middle East, Africa and Latin America HMO Infant Formula Sales by Type (2024-2029) & (Tons)
• Table 99. Middle East, Africa and Latin America HMO Infant Formula Revenue by Type (2018-2023) & (US$ Million)
• Table 100. Middle East, Africa and Latin America HMO Infant Formula Revenue by Type (2024-2029) & (US$ Million)
• Table 101. Middle East, Africa and Latin America HMO Infant Formula Sales by Application (2018-2023) & (Tons)
• Table 102. Middle East, Africa and Latin America HMO Infant Formula Sales by Application (2024-2029) & (Tons)
• Table 103. Middle East, Africa and Latin America HMO Infant Formula Revenue by Application (2018-2023) & (US$ Million)
• Table 104. Middle East, Africa and Latin America HMO Infant Formula Revenue by Application (2024-2029) & (US$ Million)
• Table 105. Middle East, Africa and Latin America HMO Infant Formula Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 106. Middle East, Africa and Latin America HMO Infant Formula Revenue by Country (2018-2023) & (US$ Million)
• Table 107. Middle East, Africa and Latin America HMO Infant Formula Revenue by Country (2024-2029) & (US$ Million)
• Table 108. Middle East, Africa and Latin America HMO Infant Formula Sales by Country (2018-2023) & (Tons)
• Table 109. Middle East, Africa and Latin America HMO Infant Formula Sales by Country (2024-2029) & (Tons)
• Table 110. Abbott Company Information
• Table 111. Abbott Description and Major Businesses
• Table 112. Abbott HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 113. Abbott HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Abbott Recent Developments
• Table 115. Nestle Company Information
• Table 116. Nestle Description and Major Businesses
• Table 117. Nestle HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 118. Nestle HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Nestle Recent Developments
• Table 120. Wyeth Nutrition Company Information
• Table 121. Wyeth Nutrition Description and Major Businesses
• Table 122. Wyeth Nutrition HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 123. Wyeth Nutrition HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Wyeth Nutrition Recent Developments
• Table 125. Hoeslandt Company Information
• Table 126. Hoeslandt Description and Major Businesses
• Table 127. Hoeslandt HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 128. Hoeslandt HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Hoeslandt Recent Developments
• Table 130. Friesland Foods Company Information
• Table 131. Friesland Foods Description and Major Businesses
• Table 132. Friesland Foods HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 133. Friesland Foods HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Friesland Foods Recent Developments
• Table 135. Hyproca Company Information
• Table 136. Hyproca Description and Major Businesses
• Table 137. Hyproca HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 138. Hyproca HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. Hyproca Recent Developments
• Table 140. Aptamil Company Information
• Table 141. Aptamil Description and Major Businesses
• Table 142. Aptamil HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 143. Aptamil HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. Aptamil Recent Developments
• Table 145. Biostime Company Information
• Table 146. Biostime Description and Major Businesses
• Table 147. Biostime HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 148. Biostime HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. Biostime Recent Developments
• Table 150. Mengniu Dairy Company Information
• Table 151. Mengniu Dairy Description and Major Businesses
• Table 152. Mengniu Dairy HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 153. Mengniu Dairy HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. Mengniu Dairy Recent Developments
• Table 155. Yili Group Company Information
• Table 156. Yili Group Description and Major Businesses
• Table 157. Yili Group HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 158. Yili Group HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 159. Yili Group Recent Developments
• Table 160. Feihe Company Information
• Table 161. Feihe Description and Major Businesses
• Table 162. Feihe HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 163. Feihe HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 164. Feihe Recent Developments
• Table 165. Junlebao Dairy Group Company Information
• Table 166. Junlebao Dairy Group Description and Major Businesses
• Table 167. Junlebao Dairy Group HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
• Table 168. Junlebao Dairy Group HMO Infant Formula Product Model Numbers, Pictures, Descriptions and Specifications
• Table 169. Junlebao Dairy Group Recent Developments
• Table 170. Key Raw Materials Lists
• Table 171. Raw Materials Key Suppliers Lists
• Table 172. HMO Infant Formula Distributors List
• Table 173. HMO Infant Formula Customers List
• Table 174. HMO Infant Formula Market Trends
• Table 175. HMO Infant Formula Market Drivers
• Table 176. HMO Infant Formula Market Challenges
• Table 177. HMO Infant Formula Market Restraints
• Table 178. Research Programs/Design for This Report
• Table 179. Key Data Information from Secondary Sources
• Table 180. Key Data Information from Primary Sources

List of Figures

• Figure 1. HMO Infant Formula Product Picture
• Figure 2. Global HMO Infant Formula Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global HMO Infant Formula Market Share by Type in 2022 & 2029
• Figure 4. 2'-Fucosyllactose (2'-FL) Product Picture
• Figure 5. 3-Fucosyllactose (3-FL) Product Picture
• Figure 6. Lactose-N-neotetraose (LNnT) Product Picture
• Figure 7. 3'-Sialyllactose (3'-SL) Product Picture
• Figure 8. 6'-Sialyllactose (6'-SL) Product Picture
• Figure 9. Global HMO Infant Formula Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 10. Global HMO Infant Formula Market Share by Application in 2022 & 2029
• Figure 11. Online Channel
• Figure 12. Specialty Store
• Figure 13. Supermarket
• Figure 14. Other
• Figure 15. HMO Infant Formula Report Years Considered
• Figure 16. Global HMO Infant Formula Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 17. Global HMO Infant Formula Revenue 2018-2029 (US$ Million)
• Figure 18. Global HMO Infant Formula Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 19. Global HMO Infant Formula Revenue Market Share by Region (2018-2029)
• Figure 20. Global HMO Infant Formula Sales 2018-2029 ((Tons)
• Figure 21. Global HMO Infant Formula Sales Market Share by Region (2018-2029)
• Figure 22. US & Canada HMO Infant Formula Sales YoY (2018-2029) & (Tons)
• Figure 23. US & Canada HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
• Figure 24. Europe HMO Infant Formula Sales YoY (2018-2029) & (Tons)
• Figure 25. Europe HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
• Figure 26. China HMO Infant Formula Sales YoY (2018-2029) & (Tons)
• Figure 27. China HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
• Figure 28. Asia (excluding China) HMO Infant Formula Sales YoY (2018-2029) & (Tons)
• Figure 29. Asia (excluding China) HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
• Figure 30. Middle East, Africa and Latin America HMO Infant Formula Sales YoY (2018-2029) & (Tons)
• Figure 31. Middle East, Africa and Latin America HMO Infant Formula Revenue YoY (2018-2029) & (US$ Million)
• Figure 32. The HMO Infant Formula Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 33. The Top 5 and 10 Largest Manufacturers of HMO Infant Formula in the World: Market Share by HMO Infant Formula Revenue in 2022
• Figure 34. Global HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 35. Global HMO Infant Formula Sales Market Share by Type (2018-2029)
• Figure 36. Global HMO Infant Formula Revenue Market Share by Type (2018-2029)
• Figure 37. Global HMO Infant Formula Sales Market Share by Application (2018-2029)
• Figure 38. Global HMO Infant Formula Revenue Market Share by Application (2018-2029)
• Figure 39. US & Canada HMO Infant Formula Sales Market Share by Type (2018-2029)
• Figure 40. US & Canada HMO Infant Formula Revenue Market Share by Type (2018-2029)
• Figure 41. US & Canada HMO Infant Formula Sales Market Share by Application (2018-2029)
• Figure 42. US & Canada HMO Infant Formula Revenue Market Share by Application (2018-2029)
• Figure 43. US & Canada HMO Infant Formula Revenue Share by Country (2018-2029)
• Figure 44. US & Canada HMO Infant Formula Sales Share by Country (2018-2029)
• Figure 45. U.S. HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 46. Canada HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 47. Europe HMO Infant Formula Sales Market Share by Type (2018-2029)
• Figure 48. Europe HMO Infant Formula Revenue Market Share by Type (2018-2029)
• Figure 49. Europe HMO Infant Formula Sales Market Share by Application (2018-2029)
• Figure 50. Europe HMO Infant Formula Revenue Market Share by Application (2018-2029)
• Figure 51. Europe HMO Infant Formula Revenue Share by Country (2018-2029)
• Figure 52. Europe HMO Infant Formula Sales Share by Country (2018-2029)
• Figure 53. Germany HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 54. France HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 55. U.K. HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 56. Italy HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 57. Russia HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 58. China HMO Infant Formula Sales Market Share by Type (2018-2029)
• Figure 59. China HMO Infant Formula Revenue Market Share by Type (2018-2029)
• Figure 60. China HMO Infant Formula Sales Market Share by Application (2018-2029)
• Figure 61. China HMO Infant Formula Revenue Market Share by Application (2018-2029)
• Figure 62. Asia HMO Infant Formula Sales Market Share by Type (2018-2029)
• Figure 63. Asia HMO Infant Formula Revenue Market Share by Type (2018-2029)
• Figure 64. Asia HMO Infant Formula Sales Market Share by Application (2018-2029)
• Figure 65. Asia HMO Infant Formula Revenue Market Share by Application (2018-2029)
• Figure 66. Asia HMO Infant Formula Revenue Share by Region (2018-2029)
• Figure 67. Asia HMO Infant Formula Sales Share by Region (2018-2029)
• Figure 68. Japan HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 69. South Korea HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 70. China Taiwan HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 71. Southeast Asia HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 72. India HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 73. Middle East, Africa and Latin America HMO Infant Formula Sales Market Share by Type (2018-2029)
• Figure 74. Middle East, Africa and Latin America HMO Infant Formula Revenue Market Share by Type (2018-2029)
• Figure 75. Middle East, Africa and Latin America HMO Infant Formula Sales Market Share by Application (2018-2029)
• Figure 76. Middle East, Africa and Latin America HMO Infant Formula Revenue Market Share by Application (2018-2029)
• Figure 77. Middle East, Africa and Latin America HMO Infant Formula Revenue Share by Country (2018-2029)
• Figure 78. Middle East, Africa and Latin America HMO Infant Formula Sales Share by Country (2018-2029)
• Figure 79. Brazil HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 80. Mexico HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 81. Turkey HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 82. Israel HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 83. GCC Countries HMO Infant Formula Revenue (2018-2029) & (US$ Million)
• Figure 84. HMO Infant Formula Value Chain
• Figure 85. HMO Infant Formula Production Process
• Figure 86. Channels of Distribution
• Figure 87. Distributors Profiles
• Figure 88. Bottom-up and Top-down Approaches for This Report
• Figure 89. Data Triangulation
• Figure 90. Key Executives Interviewed